First Hawaiian Bank Buys 1,656 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

First Hawaiian Bank increased its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 22.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,089 shares of the company’s stock after acquiring an additional 1,656 shares during the period. First Hawaiian Bank’s holdings in USANA Health Sciences were worth $441,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of USNA. Quest Partners LLC purchased a new position in shares of USANA Health Sciences in the fourth quarter valued at about $66,000. CWM LLC increased its holdings in USANA Health Sciences by 49.6% during the 4th quarter. CWM LLC now owns 1,267 shares of the company’s stock valued at $68,000 after purchasing an additional 420 shares during the period. Trexquant Investment LP bought a new position in USANA Health Sciences during the 4th quarter valued at approximately $266,000. Louisiana State Employees Retirement System purchased a new stake in USANA Health Sciences in the 4th quarter worth approximately $300,000. Finally, Summit Global Investments bought a new stake in shares of USANA Health Sciences in the 4th quarter worth approximately $307,000. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at USANA Health Sciences

In related news, CFO G Doug Iiekking sold 5,198 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total value of $232,662.48. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, major shareholder Myron W. Wentz sold 13,496 shares of the firm’s stock in a transaction that occurred on Friday, June 14th. The shares were sold at an average price of $45.03, for a total transaction of $607,724.88. Following the completion of the sale, the insider now owns 7,864,345 shares of the company’s stock, valued at $354,131,455.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO G Doug Iiekking sold 5,198 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total value of $232,662.48. The disclosure for this sale can be found here. Over the last quarter, insiders sold 31,591 shares of company stock valued at $1,458,098. Corporate insiders own 0.33% of the company’s stock.

USANA Health Sciences Stock Performance

Shares of NYSE:USNA opened at $45.56 on Friday. The stock has a 50 day moving average price of $46.07 and a 200-day moving average price of $48.15. The firm has a market capitalization of $867.92 million, a P/E ratio of 14.19, a P/E/G ratio of 1.37 and a beta of 0.93. USANA Health Sciences, Inc. has a 52-week low of $41.45 and a 52-week high of $69.60.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, April 30th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.17. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. The firm had revenue of $227.80 million for the quarter, compared to analysts’ expectations of $223.27 million. On average, equities analysts forecast that USANA Health Sciences, Inc. will post 2.78 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, DA Davidson decreased their target price on USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating for the company in a report on Tuesday, May 7th.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.